Clostridium Difficile and Inflammatory Bowel Disease

被引：49
作者：
Ananthakrishnan, Ashwin N. [2 ]
Issa, Mazen [2 ]
Binion, David G. [1 ]
机构：
[1] Univ Pittsburgh, Sch Med, UPMC IBD Ctr, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15213 USA
[2] Med Coll Wisconsin, Div Gastroenterol & Hepatol, Milwaukee, WI 53226 USA
来源：
GASTROENTEROLOGY CLINICS OF NORTH AMERICA | 2009年 / 38卷 / 04期
关键词：
Clostridium difficile; Inflammatory bowel disease; Crohn disease; Ulcerative colitis; Colectomy; TOXIN-A; PSEUDOMEMBRANOUS COLITIS; RISK-FACTORS; DIARRHEA; INFECTION; VANCOMYCIN; METRONIDAZOLE; DIAGNOSIS; ENTERITIS; OUTBREAK;
D O I：
10.1016/j.gtc.2009.07.003
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
The past decade has seen an alarming increase in the burden of disease associated with Clostridium difficile. Several studies have now demonstrated an increasing incidence of C difficile infection in patients with inflammatory bowel disease (IBD) with a more severe course of disease compared with the non-IBD population. This article summarizes the available literature on the impact of C difficile infection on IBD and discusses the various diagnostic testing and treatment options available. Also reviewed are clinical situations specific to patients with IBD that are important for the treating physician to recognize.
引用
收藏
页码：711 / +
页数：19
相关论文
共 90 条
  • [1] Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease
    Ananthakrishnan, A. N.
    McGinley, E. L.
    Binion, D. G.
    [J]. GUT, 2008, 57 (02) : 205 - 210
  • [2] [Anonymous], GASTROENTEROLOGY S1
  • [3] ARIF M, 2007, GASTROENTEROLOGY, V132, pA513
  • [4] Treatment of Clostridium difficile-associated disease:: old therapies and new strategies
    Aslam, S
    Hamill, R
    Musher, DM
    [J]. LANCET INFECTIOUS DISEASES, 2005, 5 (09) : 549 - 557
  • [5] Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains
    Barbut, F
    Decré, D
    Lalande, V
    Burghoffer, A
    Noussair, L
    Gigandon, A
    Espinasse, F
    Raskine, L
    Robert, J
    Mangeol, A
    Branger, C
    Petit, JC
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 2005, 54 (02) : 181 - 185
  • [6] ANTIBIOTIC-ASSOCIATED PSEUDOMEMBRANOUS COLITIS DUE TO TOXIN-PRODUCING CLOSTRIDIA
    BARTLETT, JG
    CHANG, TW
    GURWITH, M
    GORBACH, SL
    ONDERDONK, AB
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1978, 298 (10) : 531 - 534
  • [7] Antibiotic-associated diarrhea
    Bartlett, JG
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (05) : 334 - 339
  • [8] Clinical recognition and diagnosis of Clostridium difficile infection
    Bartlett, John G.
    Gerding, Dale N.
    [J]. CLINICAL INFECTIOUS DISEASES, 2008, 46 : S12 - S18
  • [9] Risk factors for Clostridium difficile infection
    Bignardi, GE
    [J]. JOURNAL OF HOSPITAL INFECTION, 1998, 40 (01) : 1 - 15
  • [10] CLOSTRIDIUM-DIFFICILE COLITIS FOLLOWING TREATMENT WITH METRONIDAZOLE AND VANCOMYCIN
    BINGLEY, PJ
    HARDING, GM
    [J]. POSTGRADUATE MEDICAL JOURNAL, 1987, 63 (745) : 993 - 994
123456789